Biologics Flashcards
Anthrax biologic approved in
Raxibacumab
Anthrax drug approved in 2016
Obiltoxaximab
Nerve agent poisoning treatment approved with animal rule
Pyridostigmine brominde
Animal rule requirements
1- well understood mechanism
2- effect demonstrated in more than one species
3- animal study endpoints clearly relate to desired benefit in humans
4- data allows for selection of an effective dose in humans
Animals used for approval of anthrax biologic (beginning with R)
White rabbits and cynomologus macaque nonhuman primates
Serogroups of cholera that cause outbreaks
01 and 0139
Cholera treatment
Generally, oral rehydrating solution
Also, give appropriate antibiotics to diminish the duration of the diarrhea
Zinc supplementation in children reduced the duration of illness and the volume of diarrhea
Cholera Vaccines
Vaxchora- live attenuated indicated against serogroup 01
Only FDA approved
90% efficacy
Shanchol & Euvichol - 65% protection for up to 5 years in endemic areas
Mycobacterium avium complex
Affects people with compromised immune function
Fever, sweats, weight loss, abdominal pain, fatigue, chronic diarrhea
MAC treatment
Clarithromycin and azithromycin
Surgical treatment in drug resistant
Clofazamine- new drug in clinical trials; FDA granted special investigational drug access (use outside of clinical trials)
Expanded access uses
1- patient and physician both willing to participate
2- no comparable therapy available
3- probable risk less than disease
4- sufficient evidence of safety and effectiveness
5- no interference with completion of clinical investigation
6- protocol of use of the product
7- patient is unable to obtain the ID under another IND or to participate in a clinical trial
Mucormycosis
Several different diseases caused by infection with fungi murcomycetes that affects people with weak immune system/ steam cell transplantation /diabetics
Murcomycosis treatment
Amphotericin B and isavuconazole
Aspergillosis
Caused by a common mold
Usually by inhalation
People with weakened immune system at greater risk
Several types
Anti-fungal treatment for mucormycosis and aspergillosis
Isavuconazole
3A4 inhibitors or inducers can affect drug concentrations